SynthaverseS.A.Status: Entity active
Manufacture of pharmaceutical preparations
KRS: 0000373032 NIP: 7122591951 REGON: 43124964500000
Overview
Registry date
2010-12-13
Share capital
$2,046,747.03
Activity description
Synthaverse is a Polish biotechnology company that has been operating since 1944, specializing in the development of immunotherapy solutions for various medical fields, including oncology, urology, gynecology, and tuberculosis treatment. The company offers products such as ONKO BCG, DAVOSTER, and DISTREPTAZA, aimed at supporting patients and the medical community.
Registered address
Uniwersytecka 10, 20-029 Lublin, Poland
Website
synthaverse.plWebsite active
Email
[email protected]Email address current
Industry
Authorized Representatives
Ownership
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | |
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $29,476,713.18 | herbapol.poznan.pl | |
| VipharmS.A. | $25,204,861.38 | vipharm.pl | |
| Farmaceutyczna Spółdzielnia Pracy "GalenaCooperative | $14,804,854.15 | galena.pl | |
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $13,568,030.73 | farmapol.pl/ | |
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | |
| Krakowskie Zakłady Zielarskie Herbapol W KrakowieS.A. | $6,962,691.89 | herbapol.krakow.pl | |
| Drwalewskie Zakłady Przemysłu BioweterynaryjnegoS.A. | $4,521,784.28 | dzpb.pl | |
| PoltregS.A. | $1,625,657.73 | poltreg.com | |
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl |
Last updated: 2026-05-29